Search

Your search keyword '"Bernstein RA"' showing total 186 results

Search Constraints

Start Over You searched for: Author "Bernstein RA" Remove constraint Author: "Bernstein RA"
186 results on '"Bernstein RA"'

Search Results

1. Dark Energy Survey Year 1 Results: A Precise H0 Estimate from DES Y1, BAO, and D/H Data

2. Cosmology from cosmic shear with Dark Energy Survey Science Verification data

3. A DARK ENERGY CAMERA SEARCH FOR AN OPTICAL COUNTERPART TO THE FIRST ADVANCED LIGO GRAVITATIONAL WAVE EVENT GW150914

4. A DARK ENERGY CAMERA SEARCH FOR MISSING SUPERGIANTS IN THE LMC AFTER THE ADVANCED LIGO GRAVITATIONAL-WAVE EVENT GW150914

5. DES13S2cmm: the first superluminous supernova from the Dark Energy Survey

6. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke

7. Antithrombotic Treatment of Embolic Stroke of Undetermined Source RE-SPECT ESUS Elderly and Renally Impaired Subgroups

8. Dark Energy Survey Year 1 results: Measurement of the baryon acoustic oscillation scale in the distribution of galaxies to redshift 1

9. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

10. Galaxy populations in massive galaxy clusters to z=1.1: colour distribution, concentration, halo occupation number and red sequence fraction

11. CMB lensing tomography with the DES Science Verification galaxies

12. Cross-correlation of gravitational lensing from DES Science Verification data with SPT and Planck lensing

13. Joint measurement of lensing-galaxy correlations using SPT and DES SV data

14. Cryptogenic stroke and underlying atrial fibrillation

15. How patients die after intracerebral hemorrhage.

19. SUPPLEMENT: 'lOCALIZATION and BROADBAND FOLLOW-UP of the GRAVITATIONAL-WAVE TRANSIENT GW150914' (2016, ApJL, 826, L13)

25. Cardioembolic Stroke.

26. Threat Appraisal and Pediatric Anxiety: Proof of Concept of a Latent Variable Approach.

27. Data Over Dogma in Treatment of Cervical Artery Dissections.

28. Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.

29. Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial.

30. Ecological Momentary Assessment of Youth Anxiety: Evaluation of Psychometrics for Use in Clinical Trials.

31. A Woman With Multifocal Ischemic Strokes and Progressive Cognitive Impairment due to Intravascular Lymphoma.

32. Cutaneous Paraneoplastic Syndrome Affecting the Hand in a Case of Underlying Waldenström Macroglobulinemia.

33. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.

34. Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial.

37. Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial.

38. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.

39. The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.

40. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.

41. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

42. Light curves of the neutron star merger GW170817/SSS17a: Implications for r-process nucleosynthesis.

43. Early spectra of the gravitational wave source GW170817: Evolution of a neutron star merger.

44. The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

45. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.

46. Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale.

47. A resident boot camp for reducing door-to-needle times at academic medical centers.

48. Management of Hand Fractures: Simple to Complex.

49. Cryptogenic Stroke: Research and Practice.

50. Cardiac magnetic resonance imaging: a new tool to identify cardioaortic sources in ischaemic stroke.

Catalog

Books, media, physical & digital resources